Classification of mismatch repair gene missense variants with PON-MMR

Human Mutation

Volumn 33, Issue 4, 2012, Pages 642-650

  Ali, Heidi ^a   Olatubosun, Ayodeji ^a   Vihinen, Mauno ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Bioinformatic prediction method; Colorectal cancer; Genetic diagnostics; Lynch syndrome

Indexed keywords

ARGININE; ASPARAGINE; GLYCINE; ISOLEUCINE; LEUCINE; PROLINE; PROTEIN MSH2; PROTEIN MSH6; SERINE; THREONINE; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; GENETIC VARIABILITY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MISMATCH REPAIR; MISSENSE MUTATION; PATHOGENIC OR NOT MISMATCH REPAIR; PATHOGENICITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN STRUCTURE; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA-BINDING PROTEINS; HUMANS; MODELS, GENETIC; MUTATION, MISSENSE; MUTS HOMOLOG 2 PROTEIN;

EID: 84858205858     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22038     Document Type: Article

References (66)

1. Altschul S, Madden T, Schaffer A, Zhang J, Zhang Z, Miller W, Lipman D. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389-3402.
2. Adzhubei IA, Steffen S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. 2010. A method and server for predicting damaging missense mutations. Nat Methods 7:248-249.
3. Bao L, Zhou M, Cui Y. 2005. nsSNPAnalyzer: identifying disease-associated nonsynonymous single nucleotide polymorphisms. Nucleic Acids Res 33:W480-482.
4. Betz B, Theiss S, Aktas M, Konermann C, Goecke T, Möslein G, Schaal H, Royer-Pokora B. 2010. Comparative in silico analyses and experimental validation of novel splice site and missense mutations in the genes MLH1 and MSH2. J Cancer Res Clin Oncol 136:123-134.
5. Bromberg Y, Rost B. 2007. SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res 35:3823-3835.
6. Calabrese R, Capriotti E, Fariselli P, Martelli PL, Casadio R. 2009. Functional annotations improve the predictive score of human disease-related mutations in proteins. Hum Mutat 30:1237-1244.
7. Capriotti E, Calabrese R, Casadio R. 2006. Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics 22:2729-2734.
8. Capriotti E, Fariselli P, Casadio R. 2005. I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 33:W306-W310.
9. Chan PA, Duraisamy S, Miller PJ, Newell JA, McBride C, Bond JP, Raevaara T, Ollila S, Nyström M, Grimm AJ, Christodoulou J, Oetting WS, Greenblatt MS. 2007. Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR). Hum Mutat 28:683-693.
10. Chao EC, Velasquez JL, Witherspoon MSL, Rozek LS, Peel D, Ng P, Gruber SB, Watson P, Rennert G, Anton-Culver H, Lynch H, Lipkin SM. 2008. Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat 29:852-860.
11. Cheng J, Randall A, Baldi P. 2006. Prediction of protein stability changes for single-site mutations using support vector machines. Proteins 62:1125-1132.
12. Cheng J, Sweredoski M, Baldi P. 2005. Accurate prediction of protein disordered regions by mining protein structure data. Data Min Knowl Discov 11:213-222.
13. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 31:3497-3500.
14. Christensen L, Kariola R, Korhonen M, Wikman F, Sunde L, Gerdes A, Okkels H, Brandt C, Bernstein I, Hansen T, Hagemann-Madsen R, Andersen C, Nyström M, Ørntoft T. 2009. Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients. Fam Cancer 8:489-500.
15. Conchillo-Sole O, de Groot N, Aviles F, Vendrell J, Daura X, Ventura S. 2007. AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics 8:65.
16. Doss CG, Sethumadhavan R. 2009. Investigation on the role of nsSNPs in HNPCC genes-a bioinformatics approach. J Biomed Sci 16:42.
17. Dosztanyi Z, Csizmok V, Tompa P, Simon I. 2005. IUPred: Web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics 21:3433-3434.
18. Dosztányi Z, Fiser A, Simon I. 1997. Stabilization centers in proteins: identification, characterization and predictions. J Mol Biol 272:597-612.
19. Dosztányi Z, Magyar C, Tusnady G, Simon I. 2003. SCide: identification of stabilization centers in proteins. Bioinformatics 19:899-900.
20. Drost M, Zonneveld JéB, van Dijk L, Morreau H, Tops CM, Vasen HF, Wijnen JT, de Wind N. 2010. A cell-free assay for the functional analysis of variants of the mismatch repair protein MLH1. Hum Mutat 31:247-253.
21. Ellison AR, Lofing J, Bitter GA. 2001. Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae. Hum Mol Genet 10:1889-1900.
22. Fan Y, Wang W, Zhu M, Zhou J, Peng J, Xu L, Hua Z, Gao X, Wang Y. 2007. Analysis of hMLH1 missense mutations in East Asian patients with suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 13:7515-7521.
23. Ferrer-Costa C, Gelpi JL, Zamakola L, Parraga I, de la Cruz X, Orozco M. 2005. PMUT: a Web-based tool for the annotation of pathological mutations on proteins. Bioinformatics 21:3176-3178.
24. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A. 2008. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26:5783-5788.
25. Heinig M, Frishman D. 2004. STRIDE: a Web server for secondary structure assignment from known atomic coordinates of proteins. Nucleic Acids Res 32:W500-502.
26. Ishida T, Kinoshita K. 2007. PrDOS: prediction of disordered protein regions from amino acid sequence. Nucleic Acids Res 35:W460-W464.
27. Ishida T, Kinoshita K. 2008. Prediction of disordered regions in proteins based on the meta approach. Bioinformatics 24:1344-1348.
28. Jäger AC, Rasmussen M, Bisgaard HC, Singh KK, Nielsen FC, Rasmussen LJ. 2001. HNPCC mutations in the human DNA mismatch repair gene hMLH1 influence assembly of hMutLalpha and hMLH1-hEXO1 complexes. Oncogene 20:3590-3595.
29. Kansikas M, Kariola R, Nyström M. 2011. Verification of the three-step model in assessing the pathogenicity of mismatch repair gene variants. Hum Mutat 32:107-115.
30. Kariola R, Hampel H, Frankel WL, Raevaara TE, de la Chapelle A, Nyström-Lahti M. 2004. MSH6 missense mutations are often associated with no or low cancer susceptibility. Br J Cancer 91:1287-1292.
31. Khan S, Vihinen M. 2007. Spectrum of disease-causing mutations in protein secondary structures. BMC Struct Biol 7:56.
32. Khan S, Vihinen M. 2010. Performance of protein stability predictors. Hum Mutat 31:675-684.
33. Kohonen-Corish MRJ, Al-Aama JY, Auerbach AD, Axton M, Barash CI, Bernstein I, Béroud C, Burn J, Cunningham F, Cutting GR, den Dunnen JT, Greenblatt MS, Kaput J, Katz M, Lindblom A, Macrae F, Maglott D, Möslein G, Povey S, Ramesar R, Richards S, Seminara D, Sobrido M, Tavtigian S, Taylor G, Vihinen M, Winship I, Cotton RGH, on behalf of contributors to the Human Variome Project Meeting. 2010. How to catch all those mutations-the report of the third human variome project meeting, UNESCO Paris, May 2010. Hum Mutat 31:1374-1381.
34. Korhonen MK, Vuorenmaa E, Nyström M. 2008. The first functional study of MLH3 mutations found in cancer patients. Genes Chromosomes Cancer 47:803-809.
35. Kosinski J, Hinrichsen I, Bujnicki JM, Friedhoff P, Plotz G. 2010. Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair. Hum Mutat 31:975-982.
36. Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, Mooney SD, Radivojac P. 2009. Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 25:2744-2750.
37. Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, Russell RB. 2003. Protein disorder prediction: implications for structural proteomics. Structure 11:1453-1459.
38. Lynch HT, Lynch JF, Attard TA. 2009. Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model. Can Med Assoc J 181:273-280.
39. Magyar C, Gromiha MM, Pujadas G, Tusnady GE, Simon I. 2005. SRide: a server for identifying stabilizing residues in proteins. Nucleic Acids Res 33:W303-305.
40. Ng PC, Henikoff S. 2003. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31:3812-3814.
41. Nyström-Lahti M, Perrera C, Räschle M, Panyushkina-Seiler E, Marra G, Curci A, Quaresima B, Costanzo F, D'Urso M, Venuta S, Jiricny J. 2002. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes Chromosomes Cancer 33:160-167.
42. Olatubosun, et al. 2012. Submitted.
43. Oliveberg M. 2010. Waltz, an exciting new move in amyloid prediction. Nat Methods 7:187-188.
44. Ollila J, Lappalainen I, Vihinen M. 1996. Sequence specificity in CpG mutation hotspots. FEBS Lett 396:119-122.
45. Ollila S, Fitzpatrick R, Sarantaus L, Kariola R, Ambus I, Velsher L, Hsieh E, Andersen MK, Raevaara TE, Gerdes A, Mangold E, Peltomäki P, Lynch HT, Nyström M. 2006a. The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC. Int J Oncol 28:149-153.
46. Ollila S, Sarantaus L, Kariola R, Chan P, Hampel H, Holinski-Feder E, Macrae F, Kohonen-Corish M, Gerdes A, Peltomäki P, Mangold E, de la Chapelle A, Greenblatt M, Nyström M. 2006b. Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein. Gastroenterology 131:1408-1417.
47. Opitz D, Shavlik J. 1996. Generating accurate and diverse members of a neural network ensemble. NIPS 8:535-541.
48. Ou J, Rasmussen M, Westers H, Andersen SD, Jäger PO, Kooi KA, Niessen RC, Eggen BJL, Nielsen FC, Kleibeuker JH, Sijmons RH, Rasmussen LJ, Hofstra RMW. 2009. Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome. Genes Chromosomes Cancer 48:340-350.
49. Pagenstecher C, Wehner M, Friedl W, Rahner N, Aretz S, Friedrichs N, Sengteller M, Henn W, Buettner R, Propping P, Mangold E. 2006. Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants. Hum Genet 119:9-22.
50. Peng K, Radivojac P, Vucetic S, Dunker AK, Obradovic Z. 2006. Length-dependent prediction of protein intrinsic disorder. BMC Bioinformatics 7:208.
51. Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, Hogervorst FBL, Hoogerbrugge N, Spurdle AB, Tavtigian SV. 2008. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29:1282-1291.
52. Raevaara TE, Gerdes AM, Lönnqvist KE, Tybjærg-Hansen A, Abdel-Rahman WM, Kariola R, Peltomäki P, Nyström-Lahti M. 2004. HNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1. Genes Chromosomes Cancer 40:261-265.
53. Raevaara TE, Korhonen MK, Lohi H, Hampel H, Lynch E, Lönnqvist KE, Holinski-Feder E, Sutter C, McKinnon W, Duraisamy S, Gerdes A, Peltomäki P, Kohonen-Ccorish M, Mangold E, MacRae F, Greenblatt M, de la Chapelle A, Nyström M. 2005. Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. Gastroenterology 129:537-549.
54. Schrödinger LLC. 2010. The PyMOL molecular graphics system, Version 1.3r1.
55. Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. 2010. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 7:575-576.
56. Shen B, Vihinen M. 2003. RankViaContact: ranking and visualization of amino acid contacts. Bioinformatics 19:2161-2162.
57. Shimizu K, Hirose S, Noguchi T. 2007. POODLE-S: Web application for predicting protein disorder by using physicochemical features and reduced amino acid set of a position-specific scoring matrix. Bioinformatics 23:2337-2338.
58. Sobolev V, Sorokine A, Prilusky J, Abola E, Edelman M. 1999. Automated analysis of interatomic contacts in proteins. Bioinformatics 15:327-332.
59. Sobolev V, Eyal E, Gerzon S, Potapov V, Babor M, Prilusky J, Edelman M. 2005. SPACE: a suite of tools for protein structure prediction and analysis based on complementarity and environment. Nucleic Acids Res 33:W39-43.
60. Takahashi M, Shimodaira H, Andreutti-Zaugg C, Iggo R, Kolodner RD, Ishioka C. 2007. Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. Cancer Res 67:4595-4604.
61. Tavtigian SV, Greenblatt MS, Goldgar DE, Boffetta P. 2008. Assessing pathogenicity: overview of results from the IARC unclassified genetic variants working group. Hum Mutat 29:1261-1264.
62. Thusberg J, Olatubosun A, Vihinen M. 2011. Performance of mutation pathogenicity prediction methods on missense variants. Hum Mutat 32:358-368.
63. Thusberg J, Vihinen M. 2009. Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics methods. Hum Mutat 30:703-714.
64. Trojan J, Zeuzem S, Randolph A, Hemmerle C, Brieger A, Raedle J, Plotz G, Jiricny J, Marra G. 2002. Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Gastroenterology 122:211-219.
65. Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT. 2004. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol 337:635-645.
66. Warren JJ, Pohlhaus TJ, Changela A, Iyer RR, Modrich PL, Beese L. 2007. Structure of the human MutSα DNA lesion recognition complex. Mol Cell 26:579-592.